MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

Search

AcelRx Pharmaceuticals Inc

Suletud

0

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+532.91% upside

AcelRx Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

25. apr 2025, 17:01 UTC

Tulu
Suurimad hinnamuutused turgudel

Aon Shares Sink After 1Q Profit Falls, Sales Miss Estimates

25. apr 2025, 16:10 UTC

Tulu
Suurimad hinnamuutused turgudel

Coursera Shares Rise After 1Q Beat, Better-Than-Expected Revenue View

26. apr 2025, 18:14 UTC

Tulu

Tech Executives Are Starting to Talk Tariffs. What It May Mean for Apple, Amazon Earnings -- Barrons.com

26. apr 2025, 15:00 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Trump 2.0 Era Brings Flurry of Crypto Deals -- WSJ

26. apr 2025, 08:20 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

25. apr 2025, 21:24 UTC

Peamised uudised

Cargo Shipments From China to the U.S. Dwindle -- WSJ

25. apr 2025, 20:50 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

25. apr 2025, 20:45 UTC

Peamised uudised

Stocks Claw Back Most of April's Tariff Losses -- WSJ

25. apr 2025, 20:39 UTC

Tulu

The Score: Tesla, Capital One, Boeing and More Stocks That Defined the Week -- WSJ

25. apr 2025, 20:37 UTC

Peamised uudised

Trump Administration Lays Out Tariff Roadmap to Streamline Trade Talks -- WSJ

25. apr 2025, 20:19 UTC

Peamised uudised

Nasdaq Climbs More Than 1% as Stocks Finish Strong Week -- WSJ

25. apr 2025, 20:15 UTC

Tulu

Week's Best: A Dividend Expert's Best Advice -- Barrons.com

25. apr 2025, 19:23 UTC

Market Talk

U.S. Natural Gas Futures Extend Weekly Losses -- Market Talk

25. apr 2025, 19:18 UTC

Market Talk

Oil Futures End Choppy Week With Losses -- Market Talk

25. apr 2025, 18:47 UTC

Market Talk

Gold Extends Pullback to Close Week -- Market Talk

25. apr 2025, 18:39 UTC

Peamised uudised

Nasdaq, Dow Industrials About Flat; Analysts Caution on Trump Tariffs -- WSJ

25. apr 2025, 18:34 UTC

Omandamised, ülevõtmised, äriostud

Goldman Sachs Upgrades Schwab Stock. Here's Why. -- Barrons.com

25. apr 2025, 18:32 UTC

Market Talk
Tulu

Global Equities Roundup: Market Talk

25. apr 2025, 18:32 UTC

Market Talk
Tulu

Carriers See Tariffs Driving Up Phone Prices, Slowing Upgrades -- Market Talk

25. apr 2025, 18:08 UTC

Tulu

Sphere Entertainment Deal Is a Win for Shareholders as Banks Take a Hit -- Barrons.com

25. apr 2025, 17:55 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 483 -- Market Talk

25. apr 2025, 17:40 UTC

Peamised uudised

Consumers Continue to Sour on the Economy -- 4th Update

25. apr 2025, 17:38 UTC

Tulu

Centene Stock Falls on Medicaid Cost Worries -- Barrons.com

25. apr 2025, 17:07 UTC

Market Talk

Oil Futures Turn Higher in Quiet Trade -- Market Talk

25. apr 2025, 16:54 UTC

Market Talk
Tulu

Mobile Carriers See Stronger Activity on Bigger Price Tags, Tariffs -- Market Talk

25. apr 2025, 16:46 UTC

Tulu

Reddit, Meta, and Pinterest Stocks Rise. How Alphabet's Earnings Are Giving Them a Boost. -- Barrons.com

25. apr 2025, 16:20 UTC

Market Talk
Tulu

Basic Materials Roundup: Market Talk

25. apr 2025, 16:12 UTC

Peamised uudised

Dow Industrials Fall; China Plans Economic Support During Trade Battle -- WSJ

25. apr 2025, 16:03 UTC

Tulu

AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts -- Barrons.com

25. apr 2025, 15:52 UTC

Market Talk

Grains Mixed on Low Volume Trade -- Market Talk

Võrdlus sarnastega

Hinnamuutus

AcelRx Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

532.91% tõus

12 kuu keskmine prognoos

Keskmine 5 USD  532.91%

Kõrge 5 USD

Madal 5 USD

Põhineb 1 Wall Streeti analüütiku instrumendi AcelRx Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

1

Osta

0

Hoia

0

Müü

Finantsandmed

$